轻中度慢阻肺的临床表型与预后异质性:一项前瞻性社区队列研究
本研究基于前瞻性社区队列,纳入 806 例轻中度慢阻肺患者并随访 3 年,分析症状、急性加重史、肺气肿、气体陷闭和气道重塑等临床表型与预后关系。结果显示肺气肿和气体陷闭与更快 FEV1 下降及更高急性加重风险相关,既往急性加重和症状仅与未来急性加重风险相关。轻中度慢阻肺临床表型重叠度低,存在显著预后异质性。
要点
- 轻中度慢阻肺肺气肿和气体陷闭提示更快肺功能下降和更高急性加重风险。
- 既往急性加重史和呼吸道症状可预测未来急性加重,但不预测肺功能下降。
- 轻中度慢阻肺各临床表型间重叠度低,需个体化精准评估和管理。
核心结论
- 轻中度慢阻肺存在不同的临床表型,且预后异质性显著。
- 准确识别表型对靶向干预、临床精准管理和改善预后具有重要价值。
研究设计与样本
- 基于前瞻性社区队列研究的基线和 3 年随访数据,纳入 806 例轻中度慢阻肺患者,其中 712 例(88%)完成 3 年随访。
- 轻中度慢阻肺定义为 FEV1/FVC < 0.70 且 FEV1 ≥ 预计值的 50%。
- 临床表型包括呼吸道症状、急性加重史、肺气肿、气体陷闭和气道重塑。
主要发现
- 与肺量正常者相比,轻中度慢阻肺患者肺气肿、气体陷闭和气道重塑更严重,急性加重风险更高,FEV1 年下降更快。
- 气流受限严重程度、呼吸道症状、肺气肿、气体陷闭以及嗜酸粒细胞表型在轻中度慢阻肺中重叠度低。
- 轻中度慢阻肺患者的 FEV1 年下降速率和急性加重发生率存在显著个体差异。
- 肺气肿和气体陷闭与更快的 FEV1 下降及更高的急性加重风险相关。
- 呼吸道症状和既往 1 年急性加重与更高的急性加重风险相关,但与肺功能下降加快无关。
临床怎么用
- 对轻中度慢阻肺患者应识别肺气肿和气体陷闭表型,以预判肺功能快速下降和高急性加重风险人群。
- 既往有急性加重史或存在明显呼吸道症状者即使气流受限较轻,也应重视预防未来急性加重。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical phenotypes, prognosis, and heterogeneity of mild-to-moderate chronic obstructive pulmonary disease (COPD) have not been systematically evaluated. RESEARCH QUESTION: Do different clinical phenotypes of mild-to-moderate COPD have different prognoses? STUDY DESIGN AND METHODS: We analysed the baseline and 3-year follow-up data of participants with mild-to-moderate COPD from a prospective community-based cohort study. Mild-to-moderate COPD was defined as a forced expiratory volume in 1 second (FEV1) / forced vital capacity ratio of < 0.70 and FEV1 ≥ 50% of the predicted value. The clinical phenotypes included respiratory symptoms, exacerbation history, emphysema, air trapping, and airway remodelling. Respiratory health outcomes included exacerbations and lung function decline over the 3-year follow-up. RESULTS: Overall, 806 participants with mild-to-moderate COPD were included, of whom 712 (88%) completed the 3-year follow-up. Participants with mild-to-moderate COPD had more severe emphysema, air trapping, and airway remodelling; increased exacerbation risk; and faster annual FEV1 decline than those with preserved spirometry. The severity of airflow obstruction, respiratory symptoms, emphysema, and air trapping, as well as the eosinophilic phenotype, had low overlap in mild-to-moderate COPD. There was significant individual variation in the annual FEV1 decline rate and exacerbation incidence among participants with mild-to-moderate COPD. Emphysema and air trapping were associated with faster FEV1 decline and higher exacerbation risk. Respiratory symptoms and exacerbations in the previous year were associated with a higher acute exacerbation risk but not with faster lung function decline. INTERPRETATION: Mild-to-moderate COPD exhibited distinct clinical phenotypes with significant prognostic heterogeneity. Accurate phenotype identification is essential for targeted intervention, clinical precision management, and prognostic improvement.
引用
- Wu, Wan, Zhou, et al. Clinical Phenotypes and Prognostic Heterogeneity of Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Prospective Community-Based Cohort Study. Chest. 2026. PMID: 42933687. doi:10.1016/j.chest.2026.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。